Winton Group LTD Collegium Pharmaceutical, Inc Transaction History

Winton Group LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$31.23 - $40.91 $1.32 Million - $1.73 Million	42,369 New	42,369 $1.64 Million
Q1 2023 May 12, 2023	BUY	$23.0 - $29.88 $325,335 - $422,652	14,145 New	14,145 $339,000
Q2 2022 Aug 10, 2022	SELL	$14.22 - $20.88 $213,314 - $313,220	-15,001 Reduced 26.91%	40,738 $722,000
Q1 2022 May 11, 2022	BUY	$17.2 - $22.5 $50,292 - $65,790	2,924 Added 5.54%	55,739 $1.14 Million
Q4 2021 Feb 10, 2022	BUY	$17.5 - $21.35 $266,455 - $325,075	15,226 Added 40.51%	52,815 $987,000
Q3 2021 Oct 28, 2021	SELL	$17.75 - $25.39 $128,474 - $183,772	-7,238 Reduced 16.15%	37,589 $742,000
Q2 2021 Aug 10, 2021	SELL	$21.74 - $25.28 $40,762 - $47,400	-1,875 Reduced 4.01%	44,827 $1.06 Million
Q1 2021 Jul 21, 2021	SELL	$19.25 - $26.1 $121,621 - $164,899	-6,318 Reduced 11.92%	46,702 $1.11 Million
Q4 2020 Feb 12, 2021	SELL	$17.83 - $22.29 $1.5 Million - $1.87 Million	-84,029 Reduced 61.31%	53,020 $1.06 Million
Q3 2020 Oct 30, 2020	SELL	$15.78 - $20.82 $628,122 - $828,740	-39,805 Reduced 22.51%	137,049 $2.85 Million
Q2 2020 Aug 05, 2020	BUY	$15.49 - $23.51 $843,786 - $1.28 Million	54,473 Added 44.51%	176,854 $3.1 Million
Q1 2020 May 11, 2020	SELL	$13.89 - $25.45 $283,606 - $519,638	-20,418 Reduced 14.3%	122,381 $2 Million
Q4 2019 Feb 13, 2020	BUY	$10.7 - $22.24 $1.22 Million - $2.54 Million	114,280 Added 400.72%	142,799 $2.94 Million
Q3 2019 Nov 08, 2019	BUY	$10.16 - $13.28 $289,753 - $378,732	28,519 New	28,519 $327,000

254

36.9M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.